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ABSTRACT
Purpose We aimed to investigate the effect of solubility param-
eter and drug concentration on the rheological behaviour of drug-
in-adhesive films intended for transdermal application.
Methods Films were prepared over a range of drug concentra-
tions (5%, 10% and 20% w/w) using ibuprofen, benzoic acid,
nicotinic acid and lidocaine as model drugs in acrylic (Duro-Tak 87-
4287 and Duro-Tak 87900A) or silicone (Bio-PSA 7-4301 and
Bio-PSA 7-4302) pressure sensitive adhesives (PSAs). Saturation
status of films was determined using light microscopy. Viscoelastic
parameters were measured in rheology tests at 32°C.
Results Subsaturated films had lower viscoelastic moduli where-
as saturated films had higher moduli than the placebo films and/or
a concentration-dependent increase in their modulus. Saturation
concentration of each drug in the films was reflected by decreasing/
increasing viscoelastic patterns. The viscoelastic windows (VWs) of
the adhesive and drug-in-adhesive films clearly depicted the effect of
solubility parameter differences, molar concentration of drug in the
adhesive film and differences in PSA chemistry.
Conclusions Drug solubility parameters and molar drug concen-
trations have an impact on rheological patterns and thus on the
adhesive performance of tested pressure sensitive adhesives
intended for use in transdermal drug delivery systems. Use of
the Flory equation in its limiting form was appropriate to predict
drug solubility in the tested formulations.
KEY WORDS acrylic adhesive . rheology . silicone adhesive .
solubility parameter . transdermal patch
ABBREVIATIONS
DMS dimethyl siloxane
LVR linear viscoelastic region
PSA pressure sensitive adhesive
TDD transdermal drug delivery
VW viscoelastic window
G′ elastic shear modulus
G″ viscous shear modulus
J creep compliance
δ solubility parameter
ω angular frequency
INTRODUCTION
Transdermal Drug Delivery (TDD) systems, commonly
also known as transdermal patches, are pharmaceutical
dosage forms intended to deliver drug across a pa-
tient’s skin into the systemic circulation at a therapeu-
tically effective rate. Since the market introduction of
transdermal patches, it has become evident that opti-
misation of their adhesive properties represents an im-
portant challenge during the pharmaceutical develop-
ment in order to minimise the risk of adhesion failure
in practice (1).
Adhesion is critical to the safety, efficacy and quality
of TDD products. There have been numerous reports
to the Food and Drug Administration (FDA) on prob-
lems caused by the lack of adhesion of patches to the
skin. Therapeutic effect is correlated to adhesive per-
formance therefore drug delivery from TDD systems
will be reduced if the surface area of contact decreases
(e.g. patch lift), leading to incorrect dosing. In addition,
the cost of treatment increases if adhesive failure occurs
during the prescribed application time because the pa-
tient will have to apply a new patch. Safety issues can
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also arise e.g. children accidentally dosed on picking up fallen
patches, or by sitting or lying on a fallen patch (2).
The pressure sensitive adhesive (PSA) is the material that
confers to the transdermal patch its adhesive ability. PSAs are
permanently tacky adhesive polymers that can stick to a
substrate by application of light pressure (stress) without re-
quiring solvent or heat. There are several possible patch
designs. With respect to main structural elements and intrinsic
release kinetics one may distinguish between reservoir- and
matrix-type systems. In our study we examined the properties
of drug-in-adhesive patches, i.e. matrix systems, in which the
drug is mixed directly with the adhesive polymer.
The European Medicines Agency has recently drafted a
guidance document on the quality of transdermal patches (3).
In this document the importance of in vitro adhesion tests is
highlighted and defined as the characterisation of the
adhesive/cohesive and viscoelastic properties of the patch. In
routine standard tests, the adhesive performance of transder-
mal patches and their batch-to-batch uniformity is evaluated
using non physiological substrates, e.g. the patch is placed on a
metal plate to determine its peel adhesion properties. In this
work, the adhesive performance is evaluated by mainly focus-
sing on the material properties manifested by the rheological
properties of the PSA. Advantageously, such measurements
do not depend on surface properties of non-physiological
substrates used in routine standard tests but purely on the
material properties; hence the variation from metal surface is
eliminated.
PSAs are viscoelastic in nature i.e. they can behave both as
viscous liquids and elastic solids; during application to a sub-
strate, PSAs behave as a viscous liquid layer that spreads onto
the substrate. The spreading is achieved by light pressure
when applying the PSA hence the name ‘pressure sensitive
adhesive’. During removal from the substrate, the PSA be-
haves as a cohesive solid to ensure complete removal without
leaving any residues. The first PSAs were made from the
addition of resin to natural rubber at appropriate ratios that
would render pressure sensitive adhesive performance to the
system (4). The tackifier resin provides the liquid behaviour by
decreasing the shear modulus at slow deformation rate when
wetting happens. The solid behaviour leads to an increase in
the modulus at higher rates when the system is removed from
the substrate. By having dual properties, PSAs require good
compromise between adhesion (surface wetting) and cohesion
(bearing load) balance.
The first approach to relate the adhesive performance of
pressure sensitive adhesives to their rheological properties can
be attributed to the work of Dahlquist (5) who suggested that
the creep compliance J of the adhesive has to be greater than
10−5 Pa−1 at low frequencies that correspond to the bonding
process. Subsequently, Chu expanded the work of Dahlquist
by a detailed and thorough analysis using dynamic rheology
testing instead of Dahlquist’s static test: Chu found that rubber
PSAs tested by him revealed an optimum combination of tack,
shear and peel properties when their elastic modulus G′
measured at different frequencies met the following criteria:
1. G′ at ω=0.1 rad/sec=2 to 4×104 Pa=2 to 4 N/cm2
2. Slope G′(at ω=100 rad/sec)/G′(at ω=0.1 rad/sec)=5 to
300 (6).
Chang further expanded the work of Dahlquist and Chu
by introducing a two dimensional box, forming a viscoelastic
window (VW). The VW is constructed via four coordinates
that correspond to the measured elastic (G′) and viscous (G″)
moduli at two frequencies; at 0.01 rad/sec (low frequency)
corresponding to bonding and at 100 rad/sec (high frequency)
corresponding to debonding. Chang subsequently constructed
the VWs of several PSAs and developed VW areas that
correlate to the adhesion performances of different types of
PSAs (7,8). A correlation between traditional tape properties
and rheological data and consistency with Chu’s criteria has
already been reported for silicone-type PSAs (9).
In this study we selected a number of low molecular weight
model drugs to investigate the impact of drug load on rheolog-
ical properties of two classes of pressure sensitive adhesive (PSA)
polymers (acrylic- and silicone-type PSAs) suitable for transder-
mal systems. Previous studies on saturated drug-in-adhesive
silicone films had shown a drug concentration-dependent in-
crease on the moduli of the films (10). In this current work we
examine both subsaturated and saturated films. The selected
silicone-type PSAs have the same chemical composition but
different solvents (ethyl acetate or n-heptane), whereas the
tested non cured acrylic-type PSAs represent chemically differ-
ent copolymers in the same solvent (ethyl acetate).
The aims of our study were:
& To study how drug load and drug solubility parameter
affect the rheological properties of pressure sensitive
adhesives.
& To correlate the rheological properties of pressure sensi-
tive adhesives and drug-in-adhesive films with existing
criteria that describe adhesive performance.
& To examine whether pre-formulation information on
drug-in-adhesive films can be utilised to predict their
adhesive performance.
MATERIALS AND METHODS
Materials
Two acrylic and two silicone PSAs were used in our study.
Duro-Tak 87-900A and Duro-Tak 87-4287, both acrylic non
cured PSAs in ethyl acetate, were supplied by National
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Adhesives-Henkel (Slough, UK). Bio-PSA 7-4301, an amine
compatible silicone PSA in n-heptane and Bio-PSA 7-4302,
an amine compatible silicone PSA in ethyl acetate were sup-
plied by Dow Corning Corporation (Midland, Michigan,
USA). Scotchpak 1020, a low adhesion release liner,
was supplied by 3 M Corporation (St Paul, USA). Four
model drugs were selected; nicotinic acid (Fluka, Bel-
gium), ibuprofen (Knoll Pharmaceuticals, BASF, UK),
lidocaine (Sigma, Taiwan) and benzoic acid (Riedel-de
Haen, Sigma-Aldrich, Germany). Ethyl acetate (purity
of 99.7%) was supplied by Sigma-Aldrich (Steinheim,
Germany) and toluene (purity of 99.7%) was supplied
by Riedel-de Haen (Seelze, Germany).
Methods
Calculation of Solubility Parameters of Model Drugs, Solvents
and Monomer Units
Solubility parameter components of solvents, acrylic and sili-
cone monomer structures and model drugs were calculated
according to the methods of Hoftyzer and Van Krevelen (11)
and Fedors (12). The molar volume data was referred from
Fedors (12). The acrylic monomer structures were drawn as if
they were in the respective polymer, by changing their double
bond (=CH2) to a single bond (-CH2-) prior to the calculation
of solubility parameter, to reflect the real structures of the
repeating monomer units as they are arranged by the poly-
merisation process. Similarly, the silanol groups (Si-OH) of
the silicone monomers were drawn in their siloxane
form (Si-O). The compositions of Duro-Tak 87-900A
and Duro-Tak 87-4287 were taken from patent publi-
cations (13–16). Both Duro-Tak 87-900A and Duro-Tak
87-4287 have 2-ethylhexyl acrylate as the main repeat-
ing monomer unit. Duro-Tak 87-4287 is a copolymer
with vinyl acetate and contains OH– functional groups as 2-
hydroxyethyl acrylate is also part of the polymer composition.
Duro-Tak 87-900A contains besides 2-ethylhexyl acrylate,
butylacrylate, methyl methacrylate and tertiary-octyl acrylam-
ide units. Bio-PSA 7-4301 and Bio-PSA 7-4302 contain MQ
silicate resin (Q=SiO4/2; M=R
1R2R3SiO1/2; R=CH3 or
OH) and PDMS poly (dimethyl siloxane) silicone polymer at
a ratio of 55:45 (17).
The chemical structures of the model drugs and monomer
units are shown on Fig. 1.
The following equations were used for the calculation of
solubility parameter δ according to Hoftyzer and Van
Krevelen’s method:
δd ¼
X
F di
v
ð1Þ
Fig. 1 Structures of model drugs and PSA monomers.
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where δd is the solubility parameter contribution of
dispersion components, Fdi is the group contribution
to the dispersion components, and V is the molar
volume.
δp ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
F 2pi
q
v
ð2Þ
where δp is the solubility parameter contribution of polar
components, Fpi is the group contribution to the polar com-
ponents, and V is the molar volume.
δh ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
Ehi
v
s
ð3Þ
where δh is the solubility parameter contribution of hydrogen
bonding components, Ehi is the hydrogen bonding energy,
and V is the molar volume.
δt ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
δ2d þ δ
2
p þ δ
2
h
q
ð4Þ
where δt is the total solubility parameter.
δA ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
δ2p þ δ
2
h
q
ð5Þ
where δA is the overall polarity.
The following equation was used for the calculation of
solubility parameters using Fedors’ method:
δ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiX
energy of vaporisationX
molar volume
vuut ð6Þ
where δ is the total solubility parameter.
Determination of Solid Content of Liquid Adhesives
Approximately 3 ml of liquid adhesive (Duro-Tak 87-900A,
Duro-Tak 87-4287, Bio-PSA 7-4301 or Bio-PSA 7-4302) was
pipetted into a previously tarred beaker and weighed accu-
rately using an analytical balance. Drying of the solvent took
place inside an oven (Memmert Model UNE 400,
Schwabach, Germany) at 40±1°C for 2 h. The beaker was
then left at ambient room temperature for an hour before
being weighed again. The process was conducted in duplicate
(n=2) for each pressure sensitive adhesive. The solid content of
each liquid adhesive was then determined as a percentage.
Results were verified by examination of residual solvent using
Headspace Gas Chromatography as described in the follow-
ing section. The mean value of solid content was subsequently
used for the calculation of the required amount of liquid
adhesive for each target% w/w drug load in the dry drug-
in-adhesive films.
Residual Solvent Analysis Using Headspace Gas Chromatography
Residual solvent in the dry adhesive was determined by
Headspace Gas Chromatography (GC) (Agilent Technologies
7890A, Santa Clara, CA, USA) using an internal standard of
toluene/N,N-dimethyl acetamide. A calibration curve was
prepared, using five solutions of n-heptane/ethyl acetate in
internal standard, for the quantification of n-heptane and
ethyl acetate in the dry adhesive samples. An accurately
weighed adhesive sample was placed into a 20 ml headspace
vial containing 5 ml of internal standard. The vial was then
capped immediately. Prior to calibration, a blank of internal
standard was injected. All adhesive samples were examined in
triplicate (n=3).
A DB-624, 30 m×0.53mm×3.0 μmGC column was used
with Helium gas as the carrier (constant flow of 35 cm/min)
with 3.5 psi gas pressure. The United States Pharmacopoeial
method, USP 467, for the Headspace analysis of organic
volatile impurities was applied. (18)
Preparation of Drug Loaded Adhesive Films
Drug-in-adhesive films with drug loading of 5%, 10% and
20% w/w were prepared in triplicate (n=3). About 15 ml of
liquid adhesive was pipetted into a previously tared glass
container. The container was quickly closed with its cap to
minimise evaporation of the solvent. The amount of model
drug needed was then calculated and added into the glass
container. Another cap which had been drilled to accommo-
date the shaft of an anchor stirrer (IKA, Staufen, Germany)
was quickly secured to the glass container andmixing was then
carried out at 65±3 rpm for 10 min using an overhead stirrer
(IKA, Staufen, Germany).
A siliconized polyester foil was cut to the required length to
fit the Erichsen Model 509/1 film coater (Hemer-Sundwig,
Germany) with the release coating side of the polyester-liner
facing up. The solvent-containing drug loaded adhesive mass
preparations were coated onto the polyester liner sheets. The
film coater was previously set to be horizontal by adjusting the
base of the coater against a spirit level. The knife blade was set
to the height of 0.60 mm by adjusting the two height adjusters
on the blade against a 0.60mm feeler gauge blade (DIN 2275)
inserted between the film coater base and the knife blade. An
oil-less vacuum pump (FB 70155, Fisherbrand) was connected
to the base of the coater to give a vacuum that ensured the
release liner was flat. The speed of the blade was set to 6 mm/
sec. The film was then dried at 40°C for 120 min using a
universal oven (Memmert Model UNE 400, Schwabach,
Germany) controlled via a computer running Celsius 2005
software (version 6.1). The oven was previously set to be
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horizontal by adjusting the base of the oven against a
spirit level. The film was laminated with another layer
of release liner as soon as it came out of the oven. It
was kept at room temperature and used for rheological
analysis within 3 weeks.
Unmedicated (placebo) adhesive preparations were also
coated in triplicate for each PSA using the above method.
Light Microscopy
Polarised light microscopic examination of all drug-in-
adhesive films was conducted using an Olympus, BH-2
microscope (Optivision Ltd, Japan) fitted with a 10×
lens, a camera (AxioCam, MRc, Carl Zeiss) and image
acquisition software (AxioVision, vs4.4., Carl Zeiss). The
drug loaded adhesive films, coated with release liners on
both sides, were observed under the microscope with
the polariser set at 45°.
Estimation of Drug Solubility in the Films
An estimate of equilibrium solute solubility was calculated for
the model drugs, using the limiting form of the Flory equation
expressed as shown in Eq. 7 (19):
ϕ1 ¼ exp− 1þ χ1½  ¼ exp− 1:34þ
ν1
RT
 δ1−δ2ð Þ
2
h i
ð7Þ
where Φ1 is the volume fraction of the solute (=drug)≈drug
mass fraction, Χ1 is the interaction parameter =
0:34þ
ν1
RT
 δ1−δ2ð Þ
2
h i
ð8Þ
ν1 is the molar volume of the drug, δ1 is the solubility
parameter of the drug, δ2 is the solubility parameter of the
polymer, R is the gas constant (8.314 J×K−1 mol−1), and T is
the selected temperature (K)=298 K.
It has to be noted that this equation is valid only if any
specific molecular interactions between drug and polymer
segments like e.g. acid base reactions or formation of defined
drug-polymer complexes can be neglected.
Rheological Tests
The rheological measurements of placebo and drug loaded
adhesive films were performed on a Bohlin Gemini 200 Ad-
vanced Rheometer (Malvern Instruments, Malvern, UK) at-
tached to a water bath (Julabo F12-MC, Seelbach, Germany)
and an oil-less compressor (Jun-Air 2000, Norresundby,
Denmark). Film samples were placed between an 8 mm di-
ameter stainless steel serrated upper parallel plate and serrat-
ed lower plate. The gap size was set to 1,000 μm.All tests were
performed in triplicate at 32±0.1°C, i.e. in the temperature
range of human skin in vivo.
Amplitude Sweep. Prior to running frequency sweep and time
temperature superposition tests, an amplitude sweep within a
stress range from 2 to 20,000 Pa was carried out in triplicate at
a fixed frequency of 1 Hz to define the linear viscoelastic
region (LVR). Frequency sweep test was subsequently carried
after setting appropriate stress and strain values which were
within the LVR.
Frequency Sweep. Frequency sweeps were conducted for each
sample at decreasing frequencies from 100 rad/sec down to
0.1 rad/sec. The mean elastic modulus (G′) and viscous mod-
ulus (G″) at 0.1 rad/and 100 rad/sec were recorded for each
sample.
Creep and Recovery. Creep tests were performed with 1800 s of
creep time and 1800 s recovery time. The constant shear stress
was set to 1,000 Pa. The mean creep compliance (J) at 1800 s
was noted for analysis.
Plotting of Viscoelastic Data in Comparison to Known Assessment
Criteria
Elastic moduli were plotted against viscous moduli at 0.1 and
100 rad/sec in log scale and compared with known accep-
tance criteria for PSAs. A slight modification was made to the
central viscoelastic window of Chang (7) bymeasuringG′& G″
at 0.1 rad/sec instead of 0.01 rad/sec, to reduce the time
requirements for the measurements, also considering that test
temperature (32°C) was also slightly increased, and that a
temperature increase has qualitatively the same impact on
the shear modulus as a decrease of the deformation frequency.
Statistical Analysis
All statistical calculations were done using SPSS 17.0 (SPSS
UK Ltd., Woking, UK). One way analysis of variance
(ANOVA) was used to analyse the frequency sweep and creep
data. One-sample t-test was used to determine the significance
of deviation from Chu’s criteria. A probability of p <0.05 was
taken as significant difference. The Scheffe method was used
as ANOVA post hoc analysis.
RESULTS
Solubility Parameters of Model Drugs and Monomer
PSA Units
The calculated solubility parameter values for the model
drugs are shown in Table I alongside their physicochemical
properties. Both methods (Fedors and Van Krevelen) gave
very similar results in their total solubility parameter. Besides,
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the model drugs covered a wide range of solubility parameter
values.
The solubility parameter values of the adhesive monomer
units and the solvents are presented in Tables II. Table III
shows the difference in solubility parameter between each
drug and the main adhesive monomer unit of each PSA and
the predicted drug solubility according to the Flory equation
(see section below).
Estimation of Drug Solubility in Films Using Modified
Form of Flory’s Equation
Using the limiting form of Flory’s equation (Eq. 7), the
solubility of all model drugs was estimated to be higher
in acrylic PSAs than in silicone PSAs (Table II). Lido-
caine had the highest estimated solubility whereas nico-
tinic acid had the lowest estimated solubility in both
acrylic and silicone PSAs.
Residual Solvent Analysis
Retention times of ethyl acetate and heptane were 2.3 min
and 3.1 min respectively. Residual content analysis in the dry
adhesive samples during the solid content determination
showed: 0.51±0.19% residual ethyl acetate in BIO-PSA
4302; 0.62±0.13 residual n-heptane in BIO-PSA 4301;
3.73±0.73% residual ethyl acetate in Duro-Tak 87-4287;
6.52±1.06% residual ethyl acetate in Duro-Tak 87-900A.
Residual solvent in all manufactured placebo and drug loaded
films was negligible, less than 0.1%. For example, residual
ethyl acetate was 0.029±0.003% in Duro-Tak 87-4287 pla-
cebo film and 0.015±0.007 in Duro-Tak 87-4287 film con-
taining 20% w/w benzoic acid.
Polarised Microscopy
Over the test time period of at least 3 weeks at uncontrolled
room temperature benzoic acid remained crystal-free at 5%
w/w load in both Duro-Tak 87-900A and Duro-Tak 87-
4287; whereas at 10% w/w load, it was soluble only in
Duro-Tak 87-900A and at 20% w/w it was suspended in
both Duro-Taks. Lidocaine and ibuprofen were soluble in
both acrylic polymers, particularly in Duro-Tak 87-900A,
whereas they were suspended in the silicone adhesives. Nico-
tinic acid was suspended at all tested concentrations in both
the acrylic-type (Duro-Tak) and silicone-type (Bio-PSA)
adhesives.
Rheological Measurements
Frequency Sweep
Films loaded with lidocaine, ibuprofen and benzoic acid, had
significantly lower elastic moduli compared to their respective
placebo films. This observation was more pronounced in the
acrylic-type PSAs (Duro-Tak) than in silicone-type PSAs (Bio-
PSAs). It was especially pronounced in Duro-Tak 87-900A
(Fig. 2a).
Duro-Tak 87-900A and Duro-Tak 87-4287. The elastic modulus
(G′) at 0.1 rad/sec of all model drugs in Duro-Tak 87-900A is
shown in Fig. 3a. Lidocaine and ibuprofen loaded films
showed a decrease in the elastic modulus (G′) with increasing
drug load whereas nicotine loaded films showed an increase in
the elastic modulus (G′) with increasing drug load. For benzoic
acid loaded films, the elastic modulus (G′) decreased from 5 to
10% w/w whereas it increased from 10 to 20% w/w drug
load. The elastic modulus (G′) at 0.1 rad/sec of all model
drugs in Duro-Tak 87-4287 is shown in Fig. 2b. With increas-
ing drug load, only lidocaine showed a decrease in the elastic
modulus (G′) while the rest of the model drugs showed an
increase in the elastic modulus (G′).
Bio-PSA 7-4302 and Bio-PSA 7-4301. The elastic modulus (G′)
at 0.1 rad/sec in Bio-PSA 7-4302 and Bio-PSA 7-4301 is
shown for all model compounds in Fig. 3a and b respectively.
In both silicone-type adhesives, G′ values consistently in-
creased with increasing drug concentrations from 5 to 20%
w/w.
In Bio-PSA 7-4302 only the G′ values of lidocaine loaded
films remained below the G′ of the placebo preparation
indicating a higher solubility of this compound in the silicone
Table I Physicochemical Properties and Calculated Solubility Parameter Values for the Model Drugs
Model
compound
Molecular weight
(Dalton)
Density
g/cm3
Molar
volume cm3/g
Total δ (MPa1/2)
Fedors method
Total δ (MPa1/2) Hoftyzer
&Van Krevelen method
δA % δA/δ
Lidocaine 234.3 1.03 228.4 19.90 19.29 8.01 41.5
Ibuprofen 206.3 1.18 175.6 20.91 19.36 7.49 19.36
Benzoic acid 122.1 1.27 96.5 24.41 22.45 10.91 22.45
Nicotinic acid 123.1 1.47 83.7 28.01 28.87 19.93 28.87
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adhesive matrix. In Bio-PSA 7-4301, the moduli of all drug
loaded films were lower than in Bio-PSA 7-4302. Also, the
moduli of all drug loaded Bio-PSA 7-4301 films, except with
nicotinic acid, were higher than the placebo’s.
Creep Test
Creep compliance of Duro-Tak 87-900A loaded with lido-
caine and ibuprofen was increasing proportionally with drug
concentration from 5% w/w to 20% w/w (Fig. 4a). For
benzoic acid the creep compliance showed an increasing trend
up to 10% w/w and then a decreasing trend when the con-
centration was further increased to 20% w/w. For nicotinic
acid, creep compliance values were decreasing as the drug
concentration was increased. Creep compliance of lidocaine
in Duro-Tak 87-4287 films (Fig. 4b) was increasing propor-
tionally with drug concentration from 5% w/w to 20% w/w.
An opposite trend was observed on ibuprofen, benzoic acid
and nicotinic acid. Similar to Duro-Tak 87-900A, films of
Duro-Tak 87-4287 loaded with lidocaine, ibuprofen and
benzoic acid had a statistically higher creep compliance com-
pared to placebo films. A decreasing trend in the creep com-
pliance of all model drugs as the drug concentration was
increased from 5% w/w to 20% w/w was observed in all
Bio-PSA 4301 and Bio-PSA 4302 films (Fig. 4c and d). Films
loaded with lidocaine, ibuprofen and benzoic acid (with solu-
bility parameters similar to the adhesivemonomer units) had a
relatively higher creep compliance compared to placebo films.
The creep compliance of Duro-Tak 87-900A (13.2×
10−4 Pa−1) was approximately three times that of Duro-Tak
87-4287 placebo (4.8×10−4 Pa−1). Both silicone-type PSAs
showed greater creep compliance (32×10−4 Pa−1) than the
acrylic-type PSAs.
Chu’s Criteria and Viscoelastic Windows (VWs)
Figures 5a and b illustrate the rheological results with respect
to Chu’s criteria. All films passed Chu’s 2nd criterion, ratio [G
′ (at ω=100 rad/sec)/G′ (at ω=0.1 rad/sec)]. All silicone
PSAs with and without drug were located in the mid of the
target region in contrast to acrylic-type films which were
found to be near the lower limit of the 2nd acceptance
criterion. For the majority of test samples there was discor-
dance with Chu’s 1st criterion; this finding is consistent with
low cohesion properties of the tested type of adhesives and
directing to a relatively low degree of crosslinking. Drug
Table II Total Solubility Parame-
ters of Adhesive Monomer Units
and Solvents Calculated Using
Hoftyzer & Van Krevelen and
Fedors Methods
Monomer unit Adhesive Total δ (MPa1/2)
(Fedor’s method)
Total δ (MPa1/2) (Hoftyzer &
Van Krevelen method)
2-ethylhexyl acrylate Duro-Tak 87-900A;
Duro-Tak 87-4287
18.86 18.09
Butyl acrylate Duro-Tak 87-900A 19.98 19.32
Methyl methacrylate Duro-Tak 87-900A 20.32 20.64
Tertiary-octyl acrylamide Duro-Tak 87-900A 19.31 18.64
2-hydroxyethyl acrylate Duro-Tak 87-4287 27.23 28.05
Vinyl acetate Duro-Tak 87-4287 21.60 21.51
DMS (dimethyl siloxane) Bio-PSA 7-4301
Bio-PSA 7-4302
15.10 –
Silicate Resin for DMS Bio-PSA 7-4301
Bio-PSA 7-4302
15.48 –
Solvent –
Ethyl acetate – 17.89 17.69
n-heptane – 15.20 14.85
Table III Total Solubility Parameter
Difference Between Model Drugs
and Main Monomers of Duro-Tak
and Bio-PSA and Predicted Drug Sol-
ubility at Equilibrium Estimated from
the Volume Fraction of the Limiting
Form of the Flory Eq. 7 (18)
Model drug Total δ (MPa½)
(Fedors method)
Total δ difference with
2-ethylhexyl acrylate
Total δ difference
with DMS
Predicted drug solubility (%)
Acrylic PSA Silicone PSA
Lidocaine 19.90 1.04 4.80 23.7 3.1
Ibuprofen 20.91 2.05 5.80 19.4 2.4
Benzoic acid 24.41 5.55 9.31 7.9 0.9
Nicotinic acid 28.01 9.15 12.91 1.5 0.1
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candidates of good solubility in the adhesives like lido-
caine, benzoic acid and ibuprofen, had significantly
lower values of G′ at 0.1 rad/sec than their placebos,
with the G′ decreasing proportionally to increasing drug
concentration. Only acrylic films loaded with nicotinic
acid passed both Chu’s criteria.
All Bio-PSA 7-4301 films, including placebo, failed the
Chu’s criterion of G′(0.1 rad/sec). Considering that Bio-PSA
7-4302 and Bio-PSA 7-4301 differ only in their solvent, ob-
served differences in G′ between these two PSAs can be
attributed to solvent effects; use of n-heptane apparently
caused a decrease in elastic moduli compared to ethyl acetate,
in tested samples. The moduli of the four PSAs are shown in
Fig. 6 and differences between the two BIO PSA types are
further illustrated in Fig. 7. Figure 8 shows that an increase of
lidocaine concentration in 87-900A shifted the moduli to the
lower left corner of the VW coordinate. Shift to the opposite
direction (i.e. to the upper right corner) was shown by benzoic
acid in Bio-PSA 7-4302 (Fig. 9). Bio-PSA 7-4302 films showed
a different trend in the shift of moduli compared to Bio-PSA
7-4301 films. Moduli of up to 10% w/w of any model drug in
Bio-PSA 7-4301 shifted to the lower left corner while the
opposite was observed for Bio-PSA 7-4302. This “mixed
response” where a 5% w/w load caused a slight shift to the
lower left of the placebo was typical of the Bio-PSA 7-4301
formulations as shown in Fig. 10.
DISCUSSION
Correlation Between Solubility Parameters of Drug
and Monomer PSA Units, with Saturation Status
and Viscoelastic Properties of the Films
Inherently, the silicone-type PSAs have lower solubility pa-
rameters as compared to the acrylic-type PSAs. Both the
dimethyl siloxane (DMS) and the resin for DMS (MQ) have
similar solubility parameters i.e. 15.10 and 15.48 MPa1/2
respectively. They should affect the solubility parameter of
the polymer quite similarly with respect to a resin:polymer
ratio of 55:45 typical for Bio-PSA 7-4300 amine compatible
silicone-type PSAs (17). Comparing the solubility parameter
of the main monomer of acrylic-type PSA (2-ethylhexyl
acrylate) to the silicone-type PSA’s monomer units, the
acrylic-type PSA’s main monomer solubility parameter is
about three units higher (15.10 and 15.48 MPa1/2 compared
to 18.86 MPa1/2).
Drug solubility in the adhesive film was dependent on the
difference in solubility parameter between the drug and the
adhesive polymer units (Table III). The amount of undissolved
drug reflected the difference between drug solubility and drug
load as shown by benzoic acid in Duro-Tak 87-900A and
Duro-Tak 87-4287; at 5%w/w load, benzoic acid was soluble
in both adhesives whereas at 10% w/w load, benzoic acid was
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soluble only in Duro-Tak 87-900A and at 20% w/w it was
suspended in both Duro-Taks).
Lidocaine, ibuprofen and benzoic acid were soluble in
acrylic polymers, particularly in Duro-Tak 87-900A, because
of the small difference in the drug/adhesive monomer solu-
bility parameters; whereas the same drugs were suspended in
the silicone adhesives due to a large δ difference. Nicotinic
acid was suspended at all tested concentrations in both the
acrylic-type (Duro-Tak) and silicone-type (Bio-PSA) adhesives
due to a large δ difference.
Our results indicate a clear influence of total solubility
parameter and saturation status of drug loaded films, on the
viscoelastic properties of the films (Figs. 2 and 3). Subsaturated
films showed lower moduli than the neat adhesive (placebo),
directed to a plasticizing effect. As lidocaine is the model drug
with the lowest solubility parameter it can be used to illustrate
the effect of the difference in solubility parameter between
drug and acrylic- or silicone-type PSA respectively. By in-
creasing the lidocaine concentration, all three moduli (G′, G
″, G*) and complex viscosity decreased in Duro-Tak 87-900A
and Duro-Tak 87-4287 but not in the Bio-PSAs where the
opposite was shown. The silicone-type PSAs have lower solu-
bility parameters compared to the acrylic-type PSAs, which
means that the solubility parameter difference between lido-
caine and silicone-type PSA is greater than the difference
between lidocaine and acrylic-type PSA. This difference is
big enough to show a very different rheological behaviour
between lidocaine-loaded acrylic-type PSAs and lidocaine-
loaded silicone-type PSAs, in agreement with different drug
solubilities in tested adhesives. Films with suspended drug
crystals tended to show higher moduli than the placebo’s,
presumably due to the presence of undissolved solids. The
observed correlation between physical state of drug and mod-
uli of the adhesive can be used for a semi-quantitative estima-
tion of drug solubility, as it can be e.g. illustrated by benzoic
acid in Duro-Tak 87-900A: Initial decrease of G′ by drug
loading is followed by an increase of G′ at a drug load above
10% w/w. The resulting U-shaped G′ profile is consistent
with the microscopic analysis showing that at 5% and 10%
w/w loading the films were subsaturated whereas at 20%w/w
there was visible drug crystallisation. Corresponding estimates
of drug solubilities in the acrylic adhesives from viscoelastic
data are shown in Table IV; the estimated solubility ranges
correlated well with the microscopic observations, confirming
that viscoelastic patterns are sensitive to the saturation status
of the films.
The microscopic observations were also in congruence
with the calculated estimates of drug solubility according to
Flory’s equation (Table II). For example, the calculated drug
solubilities in silicone PSAs were all lower than 5% w/w, in
agreement with microscopic observations; in acrylic PSAs all
calculated values were within the drug solubility concentration
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ranges that were observed via microscopy. Therefore, the limit-
ing form of Flory’s equation was shown to be a useful tool for the
calculation of drug solubility in silicone and acrylic drug-in-
adhesive films, based on solubility parameter differences.
Deviations from microscopic results and estimates based on
solubility parameters of drug and monomer PSA units can be
anticipated when plasticizing effects of molecularly dispersed
drug amounts are dominating over any cohesion strengthening
effects exerted by suspended drug crystals. Such situation may
explain results obtained on samples with 5% w/w nicotinic acid,
where moduli with suspended drug crystals were statistically
similar to their corresponding placebos (Fig. 2a and b), and on
Duro-Tak 87-4287 samples with 20% lidocaine, where the
modulus was lower than 10% lidocaine although sporadic crys-
tals were already detectable in these films (Fig. 2b). Accordingly,
drug solubility estimates from rheological measurements have to
be interpreted with care, especially when drug solubility is similar
to tested drug concentration as demonstrated for 5% w/w
nicotinic acid and 20% w/w lidocaine.
Cold flow of the adhesive during storage can compromise the
smooth removal of the patch from the primary package. During
application to the skin, creeping of the drug loaded adhesive
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might lead to “black rings” surrounding the patch and/
or to patch adherence to clothes covering the applica-
tion site. Measured creep compliance data was in con-
gruence with the frequency sweep results, directing to
increased cold flow for subsaturated drug-in-adhesive
films and decreased cold flow for films containing
suspended drug particles, compared to placebo films
(Fig. 4).
Viscoelastic Parameters as Assessment Criteria
for Adhesive Performance
Tack or bonding, requires low elastic (storage) and viscous
(loss) shear moduli to enable the material to adequately de-
form, flow and adhere on skin surfaces of different contours
(a) Elastic shear modulus measured at 0.1 rad/sec 
(b)  Ratio of the elastic moduli measured at 100 rad/sec and 0.1 rad/sec 
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and texture. Considering that Young’s modulus of skin was
reported to be between 0.1 and 0.3 MPa, the elastic modulus
of the patch should be of the same order to allow skin to move
in a physiological way at the application site (20). In contrast,
peel or debonding requires high elastic shear—and viscous
moduli at high frequencies, to enable the removal of the
material without cohesive failure from the skin surface (21).
Figure 7 depicts elastic and viscous moduli of tested drug free
adhesives measured at two different frequencies in relation to
published fundamental viscoelastic requirements for pressure
sensitive adhesives, considering target performance in terms of
tack, shear and peel properties.
It is evident that all four drug-free adhesives have a bond-
ing modulus G′ at 0.1 rad/sec much below the Dahlquist
criteria line (shear modulus G′=330,000 Pa), as to be antici-
pated for materials that are “contact efficient” or tacky.
TheG′-G″ cross-over line separates regions where the elastic
modulus G′ is greater (i.e. tan δ <1) or smaller (tan δ >1) than
the viscous modulus G″. As illustrated, bonding moduli mea-
sured at 0.1 rad/sec are located in the more elastic region for
the acrylic systems, and in the more viscous region for the
silicone adhesives. Overall, all values at low frequency mea-
sured at 32°C comply with or are very close to the viscoelastic
window proposed by Chang (8) for “general purpose” PSAs,
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with G″ and G′ values falling into a region of 104 to 105 Pa at
0.01 rad/sec and 100 rad/sec. At high frequency, moduli were
clearly lower for the acrylic adhesives remaining below the
Dahlquist’s criteria line, in contrast to the high tack BIO-
PSAs 4302/4301. However, despite the much higher G″
and G′ values the silicone adhesives still meet the 2nd Chu
criterion for the upper and lower G′ value calculated based on
the G′ ratio at low and high frequencies and the optimum G′
range at low frequency. Note: According to Chu’s 2nd crite-
rion the ratio [G′ (at ω=100 rad/sec)/G′ (at ω=0.1 rad/sec)]
equals 5 to 300. I.e. lower limit=(5×20,000 Pa)=100,000 Pa
and upper limit=(300×40,000 Pa)=12,000,000 Pa.
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All tested drug-free adhesives are slightly below the 1st Chu
criterion, suggesting that moduli might have to be slightly
increased to achieve optimum target of shear, tack and peel
properties.
The adhesive/cohesive balance of the test material can be
generally evaluated according to its location relative to the
central viscoelastic window (VW) defined by Chang, consid-
ering that the elastic modulus (G’) reflects the strength against
deformation and that the viscous modulus (G″) is indicative of
dissipation i.e. flow of the material. According to Chang the G
″/G′ is subdivided into four quadrants with a central one (only
depicted in Fig. 7) representing the following material
properties:
& The left quadrant of high G′ and low G′, can be assigned
to materials without PSA properties.
& The right upper quadrant characterized high G′ and G″
values is typical for PSAs of high shear strength.
& The right lower quadrant can be attributed to PSAs of low
cohesive strength and high dissipation which is favourable
to cold temperature PSAs requiring good flow properties
at low temperatures
& The left lower quadrant of can be assigned to removable
PSAs of low elastic and viscous modulus.
& As mentioned the central quadrant corresponds to general
purpose PSAs, described by medium cohesive strength
and dissipation properties.
Chu’s criteria lines illustrate the G′ corridors found for
hydrocarbon rubber-based adhesives with an optimum bal-
ance of tape properties, i.e. shear, peel, tack.
For example, drug loading of Duro-Tak 87900A with
lidocaine leads to shift of the G″/G′ data pairs towards the
lower left corner of the diagram indicating decrease of the
cohesive strength (Fig. 8). A shift into the opposite direction
(i.e. to the upper right corner) would accordingly mean in-
creasing cohesive strength as shown by the benzoic acid in
Bio-PSA 7-4302 and Bio-PSA 7-4301 (Figs. 9 and 10).
Effect of Molar Drug Concentration on the Viscoelastic
Properties of the Films
Figures 11a and b illustrate that drugs having quite similar
solubility parameters (ibuprofen, lidocaine) also have quite
similar elastic moduli at similar molar concentrations,and that
drugs which are more different to this respect (benzoic acid,
nicotinic acid) differ also more in their elastic moduli. There-
fore, knowledge of the solubility parameter of the drug at the
preformulation stage is useful to predict the rheological re-
sponse to concentration changes in drug loaded films. The U-
shape behaviour of benzoic acid in Duro-Tak 87-900A
(Fig. 2a) can be attributed to its higher molar concentration
at 20 wt.% load combined with a solubility parameter higher
than lidocaine and ibuprofen which explains a lower solubility
in the acrylic film.
The elastic moduli of nicotinic acid which are significantly
different from the other drug-loaded acrylic PSAs and Bio-
PSA 7-4302 represent rheological behaviour of these films
containing actives with low solubility parameters.
In Bio-PSA 7-4301, nicotinic acid and ibuprofen exhibited
the same elastic modulus at same molar concentrations; this
was also observed for lidocaine and benzoic acid. Both silicone
PSAs have the same chemical composition. The difference
specified by the supplier is the solvent for the adhesive solids;
heptane is used for Bio-PSA 7-4301 and ethyl acetate for Bio-
PSA 7-4302. Therefore data are directing to a potential
impact of solvents on adhesive performance of drug loaded
matrix films. In tested silicone adhesives, dipole-dipole
Table IV Drug Solubility Ranges
Estimated from Rheological and
Microscopic Data in Comparison to
Drug Solubility Predicted by the
Flory Equation (see also Table III).
Drug Load of Duro-Tak Adhesives is
Corrected for Measured Mean Sol-
vent Residues in Pure Adhesives
PSA Model drug Drug solubility estimate
from rheological data
(% w/w)
Drug solubility estimate
from microscopic data
(% w/w)
Drug solubility estimate from
limiting form of Flory equation
(% w/w)
87-900A Lidocaine > 22.5 ≥ 22.5 23.7
Ibuprofen > 22.5 ≥ 22.5 19.4
Benzoic acid 11.2–22.5 < 11.2 7.9
Nicotinic acid < 5.6 < 5.6 1.5
87-4287 Lidocaine > 21.0 < 21.0 23.7
Ibuprofen < 22 < 22 19.4
Benzoic acid < 10.5 < 10.5 7.9
Nicotinic acid < 5.2 < 5.2 1.5
Bio-PSA Lidocaine < 5 < 5 3.1
Ibuprofen < 5 < 5 2.4
Benzoic acid < 5 < 5 0.9
Nicotinic acid < 5 < 5 0.1
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interactions with the drug and solvent molecules might have
causedminor structural changes in the PDM/silicate network.
However, to further explain the observed solvent-dependent
shift of moduli in 4302 and 4301 type adhesives, further
studies are needed which expand the scope of this investiga-
tion. Regardless of the described solvent impact, the effect of
molar drug concentration on rheology was detectable also in
the 4301 adhesive silicone adhesives, whereby the paired
drugs, nicotinic acid/ibuprofen and lidocaine/benzoic acid,
exhibited nearly identical viscoelastic moduli at the same
molar concentrations.
Correlation with Chu’s Criteria
It has to be considered that Chu’s criteria were based on
results generated on blends of natural or synthetic rubber with
tackifiers. Such tackifying ingredients are not per se needed for
acrylic-type PSAs. Their adhesion/cohesion properties are
varied by copolymer composition rather than by addition of
a tackifying agent. Accordingly, extension of Chu’s criteria to
other types of PSAs has to be done with caution (22). As
shown, the tested acrylic adhesives are close to Chu’s criteria
postulated for an optimum of peel, tack and shear properties,
confirming the general approach based onG′measurement at
different frequencies also for this type of adhesive.
For silicone-type pressure adhesives a correlation between
traditional tape properties and rheological data and consis-
tency with Chu’s criteria has been already reported some
years ago (9). Tested silicone adhesives had a lower G′ mod-
ulus at 0.1 rad/sec compared to the acrylic films. For example,
the bonding modulus G′ can be increased by a slightly higher
silicate resin portion in the reaction product with the PDMS
polymer. As too high resin content would reduce tack prop-
erties, adjustment of the polymer/resin ratio has to be care-
fully tailored to the needs of the formulation. G′ values of 4302
and 4301 adhesives meet the 2nd criteria of Chu at high
frequency, indicating good peel adhesion. Compared to the
acrylics shear modulus G′(100 rad/sec) of the silicone adhe-
sives is much higher, suggesting that moduli range at high
frequencies can be relatively broad without compromising
Drug conc (mol/100g)
0.0 0.2 0.4 0.6 0.8 1.0 1.2
El
as
tic
 m
od
ul
us
 a
t 0
.1
 ra
d/
se
c 
(N
/cm
²)
0
1
2
3
4
5
Lid/87-900AA1 
Lid/ 87-4287 
Lid/ 4302
Lid/4301
lIbu/87-900A 
Ibu/87-4287
lIbu/4302
Ibu/4301
Placebo (Acrylate)
Lid
Placebo (Silicone)
 Ibu/ 4302
 Ibu/ 4301
Ibu/ D 87-4287
Ibu/ D 87-900A
Lid/ D 87-900A
Lid/ D 87-4287
 Lid/ 4302
 Lid/ 4301
(b) 
(a) 
Drug conc. (mol/100g)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
El
as
tic
 m
od
ul
us
 a
t 0
.1
 ra
d/
se
c 
(N
/cm
²)
0
1
2
3
4
5
BA/87-900A
BA/87-4287
BA/4302
BA/4301
Nic/87-900A
Nic/87-4287 
Nic/4302
Nic/4301Placebo (Acrylate)
Placebo (Silicone)
 Nic/ 4302
Nic/ 4301
Nic/ D 87-900A
Nic/ D 87-4287
BA / D 87-900A
BA/ D 87-4287
 BA/ 4302
BA/ 4301
Fig. 11 Elastic moduli of tested
adhesives at different nominal molar
drug loads, comparison of drugs
with (a) similar (lidocaine and
ibuprofen), (b) different solubility
parameters (benzoic acid and
nicotinic acid).
Viscoelastic Performance of Drug-in-Adhesive Systems
target optimum of ad-/cohesion properties when comparing
different classes of adhesives.
Impact of Adhesive Chemistry on the Viscoelastic
Properties
Different rheological behaviour of acrylic and silicone based
polymers as depicted in Fig. 7 can be also demonstrated by
creep tests results, showing greater cold flow for the silicone
PSAs.
The creep compliance of Duro-Tak 87-900A (13.2×
10−4 Pa−1) was approximately three times that of Duro-Tak
87-4287 placebo (4.8×10−4 Pa−1) which means that Duro-
Tak 87-900A will show higher cold flow than Duro-Tak 87-
4287 under constant creep pressure. Comparing the acrylic-
type PSA to silicone-type PSA, both silicone-type PSAs
showed even greater creep compliance (32×10−4 Pa−1).
These observed differences in the viscoelastic properties
between tested acrylic-type PSAs and silicone-type PSAs can
be attributed to their different chemistry, reflecting basically
different physico-chemical properties of carbon and silicone
based adhesive polymers. For both types of adhesives ade-
quate creep compliance can be adjusted by addition of cross-
linking agents and/or appropriate solids which will reduce
cold flow properties and increase resistance to deformation.
For example, in the case of silicone-based polymers the silicate
resin portion has to be optimized with respect to effects caused
by selected drug load.
CONCLUSION
Observed drug solubilities in the polymers were in agreement
both with solubility parameter differences calculated for mod-
el compounds and adhesive monomers and the calculated
volume fraction solubility using the limiting form of the well-
known Flory equation as suggested by Fedors for estimation of
water solubility in hydrocarbon polymers (19). As such, solu-
bility parameter can be regarded as a powerful tool to predict
drug solubility at an early development stage in those TDD
systems for which specific molecular drug-polymer interac-
tions can be neglected.
Drug suspensions typically caused an increase of the elastic
modulus and decrease of creep compliance, dependent on the
drug concentration of the adhesive film. An opposite effect
was observed for solution matrices, where dissolved drug
amounts were acting as softening agents. The observed impact
of different load, solubility parameters and physical state of the
selected compounds on viscoelastic properties of the adhesive
has to be correspondingly considered when other ingredients
like stabilising agents or skin penetration enhancers have to be
added to the adhesive film. In addition, the effect of any
concentration changes of drug and additives due to release
to human skin must be taken into consideration in TDD
formulation studies to ensure that the viscoelastic properties
of the transdermal patchmatrix are kept in a target range over
the intended application period.
Described rheology studies are essential to specify an ap-
propriate application window for viscoelastic parameters like
elastic and viscous moduli for both raw materials and drug
loaded formulations during development of TDD systems.
Such specifications have to be supported by in vivo studies,
which expand the scope of this study. Our investigations
suggest that the known Chu criteria for rubber/resin based
adhesives are useful also for acrylic- and silicone PSAs. Fur-
ther research work in this field will show if and how these
criteria and the CHANG application window have to be
adapted for other adhesive formulations, different skin regions
and conditions. In any case, physiological skin movement at
the application site should not be compromised by too high
elastic moduli of the patch formulation. Accordingly, this
parameter has to be optimized together with other critical
quality attributes, which are relevant for the adhesive perfor-
mance like e.g. adhesive film thickness and type of backing.
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